(PRWEB) April 22, 2013
The US Drug Watchdog is now urging women victims of a transvaginal mesh failure involving an unsuccessful revision surgery, or a medical condition known as erosion to call them for the names of top national caliber attorneys, and because the damages are so severe, and gender specific the group is promising at least initially the attorneys will all be women. No other Group is offering a service like this. According to court records transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and or stress urinary incontinence. The procedure to install a transvaginal mesh product was supposed to be minimally-invasive. The FDA is now saying transvaginal mesh failures is causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses. The US Drug Watchdog is now expanding their national initiative designed to help women recipients of a transvaginal mesh product, who are now severely injured. For more information women, who are victims of a transvaginal mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-6466.
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implants may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh failure. If you have a friend, or loved one who is a recipient of a transvaginal mesh medical product that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. We want to make certain all women, who are transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10650206.htm.
Copyright©2012 Vocus, Inc.
All rights reserved